MicroRNA‐505‐5p/‐3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF1
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.23842 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Souichi Oe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Kansai Medical University, Osaka, Hirakata, Japan. Hauptthemen laut MEDLINE: MicroRNAs, Temozolomide, Glioma, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: This work was supported by JSPS KAKENHI [grant numbers JP18K15009 (to SO) and JP21K06763 (to SO)] and a research grant from the Kansai Medical University (KMU)…, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Mesenchymal glioma stem cells (MES‐GSCs) are a major subtype of GSCs that reside within glioma tissues and contribute to metastasis, therapy resistance, and glioma recurrence. However, the precise molecular mechanisms governing MES‐GSC functions remain elusive. Our findings revealed that expression levels of miR‐505‐5p/‐3p are elevated in MES‐GSCs compared with those in proneural (PN)‐GSCs, glioma cell lines, and normal brain tissue and that miR‐505‐5p/‐3p expression levels are decreased in differentiated MES‐GSCs. We assumed that miR‐505‐5p/‐3p would play distinctive roles in MES‐GSCs and performed loss‐of‐function experiments targeting miR‐505‐5p/‐3p. Knockdown of miR‐505‐5p/‐3p increased proliferation and promoted differentiation in MES‐GSCs while suppressing invasion, temozolomide resistance, and enhancing apoptosis in MES‐GSCs. Mechanistically, miR‐505‐5p/‐3p directly targets the 3′ UTR of AUF1, leading to its repression in MES‐GSCs. Notably, AUF1 expression levels were significantly lower in MES‐GSCs compared with those in PN‐GSCs, glioma cell lines, and normal brain tissues. Co‐inhibition of AUF1 expression with miR‐505‐5p/‐3p knockdown ameliorated the observed cellular phenotypes caused by miR‐505‐5p/‐3p knockdown in MES‐GSCs. These results suggest that miR‐505‐5p/‐3p exerts MES‐GSC‐specific roles in regulating proliferation, differentiation, invasion, apoptosis, and temozolomide resistance by repressing AUF1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Kansai Medical University, Osaka, Hirakata, Japan.
- Department of Physiology, Institute of Biomedical Science, Kansai Medical University, Osaka, Hirakata, Japan.
- Department of Neurosurgery, Kansai Medical University, Osaka, Hirakata, Japan.
- Faculty of Nursing, Kansai Medical University, Osaka, Hirakata, Japan.
ORCID-Profile: Souichi Oe
Förderung
- This work was supported by JSPS KAKENHI [grant numbers JP18K15009 (to SO) and JP21K06763 (to SO)] and a research grant from the Kansai Medical University (KMU)…
- Japan Society for the Promotion of Science
Zitieren
APA
Oe, S., Kakizaki, R., Sakamoto, S., Sato, T., Hayashi, M., Isozaki, H., Nonaka, M., Iwashita, H., Hayashi, S., Koike, T., Seki-Omura, R., Nakano, Y., Sato, Y., Hirahara, Y., & Kitada, M. (2025). MicroRNA‐505‐5p/‐3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF1. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23842
Vancouver
Oe S, Kakizaki R, Sakamoto S, Sato T, Hayashi M, Isozaki H, et al. MicroRNA‐505‐5p/‐3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF1. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23842
BibTeX
@article{Oe2025,
author = {Oe, Souichi and Kakizaki, Rio and Sakamoto, Sumika and Sato, Teruhide and Hayashi, Mikio and Isozaki, Haruna and Nonaka, Masahiro and Iwashita, Hikaru and Hayashi, Shinichi and Koike, Taro and Seki-Omura, Ryohei and Nakano, Yousuke and Sato, Yuki and Hirahara, Yukie and Kitada, Masaaki},
title = {MicroRNA‐505‐5p/‐3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF1},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.23842}
}
EUVIMED